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ABSTRACT  A rat monoclonal antibody against yeast a-tubulin  (clone YL 1/2;  Kilmartin, J. V., 
B. Wright,  and C.  Milstein,  1982, J.  Cell  Biol.,  93:576-582) that reacts specifically with  the 
tyrosylated form of a-tubulin and readily binds to tubulin in microtubules when injected into 
cultured  cells  (see Wehland,  J.,  M.  C.  Willingham,  and  I.  V.  Sandoval,  1983, J.  Cell  Biol., 
97:1467-1475)  was  used  to  study  microtubule  organization  and  function  in  living  cells. 
Depending on the concentration of YL 1/2 that was injected the following striking effects were 
observed: (a) When  injected at a low concentration (2 mg IgG/ml in the injection solution), 
where microtubules were decorated without changing their distribution,  intracellular move- 
ment of cell organelles  (saltatory  movement) and cell translocation were not affected. Inter- 
mediate concentrations (6 mg IgG/ml) that induced bundling but no perinuclear aggregation 
of microtubules abolished saltatory movement and cell translocation, and high concentrations 
(>12  mg  IgG/ml)  that  induced  perinuclear  aggregation  of  microtubules  showed  the  same 
effect.  (b) YL  1/2,  when  injected  at intermediate  and  high concentrations, arrested  cells  in 
mitosis.  Such  cells  showed  no  normal  spindle  structures.  (c)  Injection  of an  intermediate 
concentration of YL 112 that stopped saltatory movement caused  little or no aggregation  of 
intermediate  filaments  and  no  dispersion  of  the  Golgi  complex.  After  injection  of  high 
concentrations,  resulting in  perinuclear aggregation  of microtubules,  intermediate filaments 
formed  perinuclear bundles and the Golgi complex  became dispersed  analogous  to results 
obtained after treatment of cells with" colcemid. (d) When rhodamine-conjugated YL 1/2 was 
injected  at  concentrations that  stopped  saltatory  movement  and  arrested  cells  in  mitosis, 
microtubule  structures could  be visualized and followed  for several  hours  in  living cells  by 
video image intensification microscopy. They showed little or no change  in distribution and 
organization during observation, even though these  microtubule structures appeared not to 
be stabilized by injected YL 1/2 since they were readily depolymerized by colcemid or cold 
treatment and repolymerized  upon drug removal  or rewarming to 37°C, respectively.  These 
results are discussed  in terms of the participation of microtubules in cellular activities such as 
cell movement and cytoplasmic organization and in terms of the specificity of YL 1/2 for the 
tyrosylated form of a-tubulin. 
As a cytoskeletal component of interphase cells microtubules 
are involved in the determination of cell shape, in cell loco- 
motion, intracellular movement, and cytoplasmic organiza- 
tion (for recent reviews see references 13,  2 l,  52).  Evidence 
for the involvement of microtubules in these cellular activities 
has mainly derived from the application of drugs that specif- 
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and in vitro. Two classes  of drugs are commonly used:  (a) 
those that disassemble microtubules such as colchicine (47, 
59) and (b), more recently, taxol, a drug that promotes assem- 
bly of microtubules and  stabilizes  them  (54,  55).  Another 
approach to study the function of defined proteins in living 
cells is the use of microinjection of specific antibodies, assum- 
ing  that  the  injected  antibody  blocks  the  function  of its 
antigen. This technique has successfully been applied first by 
Mabuchi and Okuno  (41)  to inhibit cytokinesis in  starfish 
blastomers by injection of antimyosin serum and recently by 
others using antibodies against proteins of intermediate fila- 
ments to study the function of this type of filaments in tissue 
culture cells (18, 34, 35, 39). 
With respect to microtubules, two classes  of monoclonal 
antibodies would be favorable for a similar approach: class A 
antibodies would interfere with the polymerization of tubulin 
into  microtubules by recognizing an  antigenic site  on  the 
tubulin dimer that is necessary for polymerization. Class  B 
antibodies would recognize a site on the tubulin dimer that is 
exposed on the surface of microtubules after polymerization; 
after binding to tubulin, such an antibody ideally should not 
interfere with polymerization and therefore should leave mi- 
crotubules intact. 
Injection of class A antibodies might induce depolymeri- 
zation of microtubules and the results should be comparable 
with those derived from the application of microtubule-de- 
polymerizing drugs  such  as  colchicine. Class  B  antibodies 
could interfere with the functions of microtubules--without 
disassembling them--as follows:  (a) by recognizing specific 
binding sites of microtubule-associated proteins (MAP) j and 
thereby displacing them, (b) by masking specific sites that are 
important for other cellular structures or proteins to interact 
with tubulin in microtubules, and (c) by sterically preventing 
interaction of other cellular structures with microtubules. 
Previously, we have characterized a monoclonal antibody 
that specifically  recognizes the tyrosylated carboxyterminus 
of a-tubulin. These studies have shown (a) that the antibody, 
although able to bind to tubulin, did not affect polymerization 
of microtubules and did not displace MAP in vitro and (b) 
that  the  antibody,  when  injected into  cultured  fibroblasts, 
readily binds to tubulin  in  microtubules and induces in  a 
concentration-dependent manner a reorganization of micro- 
tubules (66). Here, we studied the effect of this antibody after 
microinjection into tissue culture cells on cellular functions 
such as intracellular movement, cell  translocation, and the 
organization of intermediate filaments and Golgi elements. 
Portions of this work have been presented in abstract form 
(64). 
MATERIALS  AND  METHODS 
Cell  Culture:  Swiss  3T3  mouse fibroblasts and A549 (human lung 
carcinoma) cells were grown in Dulbecco's modified Eagle's medium containing 
10% fetal calf serum. PtK2 (rat kangaroo) and CHO (Chinese hamster ovary) 
cells were grown in  HAM's Ft2  medium containing 5%  fetal calf serum. 
Microinjection and immunofluorescence  procedures have been previously de- 
scribed (63). Stock solutions of colcemid (Gibco Laboratories, Grand Island, 
NY) nocodazole (Sigma Chemical Co., St.  Louis, MO), and taxol (National 
Cancer Institute) were made in DMSO. For electron microscopy, cells were 
grown in plastic dishes, fixed and embedded in situ, and processed following a 
Abbreviations used in this paper:  CHO,  chinese hamster ovary; 
MES,  2-(N-morpholino)ethanesulfonic  acid;  and  MAPs,  microtu- 
bule-associated proteins. 
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method previously described (67). 
Antibodies:  Rat monoclonal antibodies to yeast a-lubulin (clones YL 
1/2 and YOL  1/34) were  a  gift of Dr.  J.  V.  Kilmartin (Medical  Research 
Council, Cambridge) (33); affinity-purified rabbit human galactosyltransferase 
polyclonal antibodies were  a  gift of Dr. E. G.  Berger  (University of Berne, 
Switzerland)  (7). Preparation and purification of rabbit polyclonal antibodies 
to tubulin from rat brain and to vimentin, isolated from CHO cells, have been 
previously described (10, 69). Direct labeling of YL 1/2 antibody with rhoda- 
mine and purification of rhodamine- and fiuorescein-conjugated goat anti- 
rabbit IgG and goat anti-rat IgG were performed as previously described (66). 
Preparation of colloidal  gold (5 nm in diameter) and adsorption to antibodies 
was performed using standard procedures (12,  15,  19). Gold-antibody com- 
plexes, prepared by Dr. D. J. P. FitzGerald (National Institutes of Health), were 
stored at 4"C in PBS containing 1% bovine serum albumin (Miles Laboratories, 
Inc., Elkhart, IN). Prior to injection, gold-antibody complexes were pelleted  in 
a Beckman Airfuge (Beckman Instruments, Inc., Palo Alto, CA) for t0 rain at 
20 psi (~ 100,000 g) and resuspended in injection buffer (0.14 M KCI, 2 mM 
MES, pH 7.2). This procedure was repeated two times and injection solutions 
were  finally centrifuged for  2  min  at  5  psi  (~20,000  g) to  remove large 
aggregates. Concentrations of antibodies on gold were based on the assumption 
that 90% of initially added antibody was adsorbed to gold particles.  In control 
experiments, purified rat IgGs (Miles)  adsorbed to colloidal  gold were used. 
Cells were normally fixed and permeabilized with cold methanol (-20"C) for 2 
min. For preparation of cytoskeletons, cells were washed with buffer A (0.1 M 
MES,  1 mM EGTA, 1 mM MgC12, 4% polyethylene glycol 6000,  pH 6.9) and 
then extracted for 30 s with buffer A containing 0.2%  Triton X-100. Cyto- 
skeletons were fixed in cold methanol (-20"C). 
Cell 5yncbroniza tion:  CHO cells were grown in plastic tissue culture 
dishes and synchronized as described by Zieve et al. (75). Tissue culture dishes 
(35 mm) were treated with poly-L-lysine at 1 mg/ml (Sigma Chemical Co.).  1 
d after plating, cells were incubated with thymidine at 2.5 mM for 15 h, then 
kept for 5 h in normal medium before nocodazole (0.04 t~g/ml) was added for 
4 h. About 80% of CHO cells were normally arrested in prometaphase by this 
method. The arrested cells divided within  1 h after removal of the drug. In 
microinjection experiments, CHO cells were injected with rhodamine-conju- 
gated YL  1/2 antibody about 2 h  before nocodazole was added.  In control 
experiments, cells were injected with purified rhodamine-conjugated IgG at the 
same concentration. For better visualization of microtubule structures, cells 
injected with YL 1/2 antibody were extracted with detergent. About 60% of all 
cells  microinjected with YL  1/2 antibody were  arrested by treatment with 
nocodazole, although some mitotic cells were probably lost during washing  and 
extraction procedures. 
Analysis of Cell  Movements and  Intensification  Micros- 
copy:  Cells grown on glass coverslips were  microinjected and transferred 
into a modified Dvorak chamber. Saltatory movements  and cell translocations 
were observed and recorded as previously described (68) using video intensifi- 
cation microscopy consisting of a SIT video camera (RCA TCI030H) coupled 
to a video monitor and a time-lapse video recorder (Panasonic NV-8030) (see 
also reference 60). Movements were normally recorded at a time-lapse ratio of 
1:72. The use ofa Zeiss ICM 405 microscope allowed the recording of phase- 
contrast micrographs directly on 35mm film during time-lapse video recording. 
For examining distribution of labeled antibody after microinjection in living 
cells, photographs were taken directly from the fluorescent screen of an EMI 
intensifier tube. This intensification system was recently described in detail 
(70). 
RESULTS 
Intracellular Movement and Cell Translocation 
Saltatory organelle movements and cell translocation were 
followed by time-lapse video intensification microscopy (68) 
after microinjection of rhodamine-conjugated YL  1/2 anti- 
body. Injection of labeled antibody allowed rapid identifica- 
tion of injected cells by video intensification microscopy and, 
when better resolution was required, enabled us to fix individ- 
ual cells, immediately after recording, to examine the distri- 
bution of injected antibody by fluorescence microscopy. In- 
jection of a low concentration of YL 1/2 (2 mg IgG/ml in the 
injection solution) that labeled microtubules without inducing 
their redistribution (66) did not affect saltatory movement or 
cell translocation. Higher concentrations that produced mi- 
crotubule bundles (6 mg IgG/ml) or aggregated microtubules 
A Monoclonal Antibody Specific for Tyrosylated a-Tubulin  1477 FIGURE  1  Saltatory organelle movements and cell locomotion of Swiss 3T3 cells after microinjection of YL  1/2  antibody.  1 h 
after injection (6 mg IgG/ml in the injection solution), video recording was started; all panels were made by photographing the 
video monitor display of stopped images from the time-lapse video record. The injected cell is located on the right side of the 
photographs, a  was  photographed 2  h  after  injection;  20  min  (b)  and  40  min  (c)  later  uninjected  cells  on  the  left  showed 
translocation in contrast to injected cell. Arrowheads in a and b indicate the nucleus in uninjected cell. Phase-dark  vesicles in the 
injected  cell  barely changed  position during observation; arrows  in  (a-c)  indicate the  same vesicle.  Note the  movement of 
uninjected cells by the altered positions of nuclei; the injected cell did not move. Bar, 20/~m. x  650. 
around the nucleus (> 12 mg IgG/ml in the injection solution) 
stopped saltatory movement and cell translocation. Although 
it is difficult to demonstrate saltatory movements in a fixed- 
time image (such as Fig. l), intracellular phase-dense lysosmes 
barely changed their position in a cell injected with an inter- 
mediate concentration (6 mg IgG/ml) (Fig.  1). An adjacent 
uninjected cell showed intense saltatory movements of lyso- 
somes when viewed by video time-lapse. The time difference 
between single exposures in Fig.  1 was  ~20 min. Therefore, 
during 40 min of observation, uninjected cells showed trans- 
location, recognized by altered position  of nuclei,  but  the 
injected cell  showed  neither  saltatory movements  nor cell 
locomotion.  Even  10  h  after  injection  YL  1/2  could  be 
detected along microtubule bundles. During this time some 
cells entered mitosis but did not progress normally through 
mitosis, i.e., they did not divide (see below). 
We wanted to examine whether other experimental condi- 
tions  that  reorganize  microtubules in  cultured  cells  effect 
saltatory movement.  One  of us has  recently described the 
effect of a nonhydrolyzable GTP-analog, guanosine 5'-[a,~- 
methylene] triphosphate (pp[CH2]pG), on microtubule orga- 
nization, cell locomotion, and saltatory movement after in- 
jection  into  cultured  cells  (65).  This GTP-analog induced 
formation of microtubule bundles resistant to colcemid, and, 
in the presence of  the drug, saltatory movement was restricted 
to cytoplasmic areas that contained microtubule bundles (65). 
Taxol has a  similar effect on microtubule reorganization 
(55),  i.e.,  it induces formation of microtubule bundles that 
are resistant to cold treatment and other microtubule-depo- 
lymerizing drugs (55). Previous reports showed that cell trans- 
location was abolished and that cell organelles were redistri- 
buted to the perinuclear area (24,  55); also,  saltatory move- 
ment was  reported to be inhibited (24).  For most of these 
studies cells were treated with taxol for ~20  h  resulting in 
drastic reorganization of microtubules (see Fig.  2,c and c'). 
We rexamined the effect of taxol with respect to  saltatory 
movement especially after shorter drug treatment. 
The time course of taxol-induced stabilization of microtu- 
bules could easily  be examined by colcemid treatments of 
cells previously incubated with taxol. Colcemid alone (1 ~M) 
depolymerized microtubules within 1 h (Fig. 2 a). When cells 
were  pretreated  with  taxol  (2  #M  for  30  min)  and  then 
incubated further with taxol (2 uM) and colcemid (1 uM) for 
1 h, microtubules remained intact and normally distributed 
FIGURE  2  Microinjection of YL 1/2 antibody into Swiss 3T3 cells before or after treatment with taxol. (a-c') Indirect immunoflu- 
orescence microscopy using YL 1/2 antibody. (a) 3T3 cells after treatment with colcemid at 1 #M for 1 h, cytoplasmic microtubules 
were destroyed. (b) 3T3 cell treated with taxol at 2/~M for 30 min and further with taxol (2/~M) and colcemid (1  #M) for 1 h, 
cytoplasmic microtubules were stabilized by taxol. (c) A 3T3 cell treated with taxol at 2 ~.M for 24 h reveals numerous microtubule 
bundles; note multinucleation in corresponding phase-contrast micrograph (c').  (d-h')  Localization of YL 1/2  antibody injected 
into 3T3 cells; at given times cells were fixed, permeabilized, and labeled with  rhodamine-conjugated goat anti-rat IgG.  (d and 
d') 2 h after injection with antibody (12 mg/ml), 3T3 cells were treated with taxol at 2 #M for 3 h. (e) 3T3 cell 5 h after injection 
of antibody (2 mg/ml). (f and f') 2 h after antibody injection (2 mg/ml), 3T3 cells were treated with taxol at 2 ~M for 3 h. (g, h, 
and h')  3T3 cells treated with taxol at 2 #M for 1 (g) or 24 h (h and h') were injected with antibody (12 mg/ml) and fixed 2 h 
later. Note that taxol treatment did not reorganize microtubules previously aggregated by injection of antibody (d and d') and 
that injection of antibody was ineffective to aggregate microtubules in cells which were pretreated with taxol (g, h, and h'). Bars, 
20/~m. (a, b, e, and h) x  450. (c, d, f, and g) x  600. 
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30 min is sufficient to stabilize microtubules (see also refer- 
ence 55). Cells treated with taxol alone for 90 min or with 
taxol  and  then  colcemid as  described  above  for Fig.  2b, 
revealed normal saltatory movement but no cell translocation, 
whereas cells  treated with taxol for 24 h  showed impeded 
saltatory movement restricted to cytoplasmic areas containing 
microtubule bundles (data not shown). 
Next we were interested whether injected YL  1/2 could 
effect the distribution  of microtubules that were stabilized 
and reorganized by previous taxol treatment or whether taxol 
could reorganize microtubules in cells previously injected with 
YL 1/2. When microtubules were aggregated by high concen- 
trations of injected antibody,  further taxol  treatment  was 
ineffective in reorganizing microtubules (Fig. 2,d and d') in 
contrast to cells previously injected with low concentrations 
of antibody (Fig. 2, e, f, and f'). When fibroblasts were prein- 
cubated with taxol for 30 min (Fig. 2g) or 24 h (Fig. 2h and 
h') and then injected with high concentrations of antibody, 
YL 1/2 altered the distribution of taxol-stabilized microtu- 
bules (in Fig. 2, compare g with b) and taxol-induced micro- 
tubule bundles (in  Fig.  2,  compare h  with c). Cells  treated 
with taxol (30 min) and then injected with YL 1/2 as in Fig. 
2g showed no saltatory movement by video time-lapse re- 
cording. Such cells  revealed microtubule bundles spanning 
the whole cytoplasm (Fig. 2g). Again,  injection of YL 1/2 at 
low concentration that did not alter microtubule organization 
in normal cells (see Fig. 2 e) did not affect saltatory movement 
in taxol-treated cells. Together with the effect of a microin- 
jected GTP-analog that  induced  microtubule bundles  and 
restricted saltatory movement along such microtubule struc- 
tures (65), and similar to results of  extended treatment of  cells 
with taxol (see above), these results suggest that the antibody 
stopped saltatory movement in  a  concentration-dependent 
manner by binding to the surface of microtubules rather than 
by inducing their bundling and aggregation. 
Mitosis 
Because 3T3 fibroblasts injected with YL 1/2 in interphase 
were able to enter mitosis but did not divide, the effect of 
different antibody concentrations on mitosis was examined. 
Low antibody concentration (2 mg IgG/ml) that did not alter 
microtubule organization in  interphase cells  did not affect 
mitosis. In contrast, intermediate concentration (6 mg IgG/ 
ml) that bundled and high concentration (>12 mg IgG/ml) 
that  aggregated  microtubules in  interphase  cells  did  affect 
mitosis.  The experiments were as follows: 
(a)  PtK2  cells  were  injected  in  prophase  with  YL  1/2 
antibody or control rat IgG (12 mg/ml in injection solution). 
2 h later, cells were fixed and injected antibodies were local- 
ized. All cells injected with control IgG had divided and were 
still connected by the midbody (not shown), whereas 80% of 
cells injected with YL 1/2 antibody did not divide. Many of 
such cells arrested in mitosis showed fluorescent bundles (Fig. 
3, b and b') that did not resemble normal spindle structures 
(Fig. 3 a). 
(b) After treatment with 2.5 mM thymidine for 15 h, CHO 
cells were incubated for 5 h  in  normal medium, and then 
nocodazole (0.04 #g/ml) was added for 4 h (75). About 80% 
of cells were arrested in prometaphase.  1 h after removal of 
nocodazole, all  cells  had  divided.  Cells  were injected with 
rhodamine-conjugated Y1  1/2 antibody or control rat IgG 
(both at 4 mg/ml) ~2 h before nocodazole was added. Fig. 
3c shows  the  distribution  of microtubules in  a  CHO  cell 
which was  previously treated with thymidine. A  CHO cell 
injected with rhodamine-conjugated YL 1/2 antibody (4 mg/ 
ml) after incubation with thymidine revealed typical micro- 
tubule bundles (Fig. 3, d and d'). For better visualization of 
injected antibody along  microtubule  structures,  cells  were 
extracted with microtubule-stabilizing buffer containing 0.2 % 
Triton X-100 and then fixed. In control experiments, syn- 
chronized CHO cells showed spindle structures typical of  cells 
in metaphase  10 min after removal of nocodazole (Fig.  3,e 
and e'). At 45 min after removal of  the drug, cells had divided 
but were still connected by the midbody (Fig. 3,fandf). 
About 60% of injected cells were arrested in prometaphase 
by nocodazole. In Fig. 3,g and g', three of the four cells were 
injected with  rhodamine-conjugated YL  1/2  antibody 2  h 
before incubation with  nocodazole, and the cells  were ex- 
tracted and fixed 25  min after removal of nocodazole. The 
uninjected cell (Fig. 3g') has already started to divide, whereas 
the  injected  cells  retained  their  round  shape  and  showed 
disoriented bundles of microtubules. At higher magnification 
(Fig. 3, h and h') these bundles resembled those observed after 
injection of YL  1/2 antibody in  interphase cells  (compare 
with Fig. 3 d). Uninjected cells divided normally (Fig. 3, i and 
i') in contrast to cells injected with YL 1/2; even 2.5 h after 
removal of the drug, injected cells could easily be identified 
by their round shape (Fig.  3,k and k').  Cells injected with 
control rat IgG divided normally. 
Intermediate  Filaments 
Treatment of fibroblasts with colcemid induces a redistri- 
bution of intermediate filaments not directly correlated with 
the disassembly of microtubules (8, 20,  32). Typical perinu- 
clear bundles of the vimentin-type filaments were observed 
FIGURE 3  Mitotic arrest  of cells  microinjected with YL  I/2 antibody. (a, b, and b') PtK2 cells fixed with formaldehyde, then 
permeabilized. (c-k') cytoskeletons of CliO cells. (a, c, e, and f) indirect immunofluorescence microscopy using YL I/2 antibody 
followed by rhodamine-conjugated goat anti-rat IgG. (a) spindle microtubules of a PtK2 cell in metaphase.  (b and b') a PtK2 cell 
was injected in early prophase  with YL I/2 antibody, 2 h later fixed, permeabilized, and labeled with fluorescent antibody. (c) 
distribution of microtubules in a CHO cell in interphase.  (d, g, h, i, and k) fluorescent micrographs  of cytoskeletons  prepared 
from CHO cells which were previously injected with rhodamine-conjugated YL I/2 antibody. (d) A CHO cell was injected with 
fluorescent YL I/2 antibody, extracted with detergent 2 h later and fixed. (e-k') CHO cells were synchronized with thymidine 
and arrested  in prometaphase  with nocodazole. (e and e')  10 min and (f and f') 45  min after removal of drug. (g-k')  after 
treatment with thymidine, CHO cells were injected with rhodamine-conjugated YL I/2 antibody, then incubated for 4 h with 
nocodazole and extracted with detergent 20 min (g and g' and h and h'), 40 min (i and u') and 2.5 h (k and k') after removal of 
the drug.  Note normal spindle formation in (e and e'), synchronized cell division in (f and f'), but absence of spindle structures 
(g and h) and inhibited cell division (i-k') in cells previously injected with YL I/2 antibody. Bars, 20 #m. (a and b) x  1,100. (c and 
d) x  1,000. (e and g) ×  750. (f) x 200. (h) x  1,250. (i) x  250. (k) x  100. 
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uM) for ~8 h (Fig. 4c). A similar result was obtained when 
YL 1/2 antibody was injected into fibroblasts at a concentra- 
tion (12 mg IgG/ml) that extensively aggregated microtubules 
in the perinuclear area (Fig. 4, d, e, andJ). Again, the vimentin 
filaments did not redistribute immediately in response to the 
reorganization and aggregation of microtubules. In this re- 
spect Blose et al. (9) were also able to induce the collapse of 
intermediate filaments in cultured cells by microinjection of 
tubulin antibodies. 
3T3 cells injected with YL 1/2 antibody at concentrations 
(6  mg  IgG/ml)  that  did  not  aggregate  microtubules  but 
stopped saltatory movements (compare with Fig.  1) did not 
show such a drastic redistribution of intermediate filaments 
(i.e., perinuclear bundles); instead, quite often a codistribution 
with microtubule structures was observed (Fig. 4,g, h, and i). 
Nevertheless, it could not be excluded that the redistribution 
of intermediate filaments was dependent on changes in cell 
morphology induced by the injected antibody (Figs. 4,g-i). 
Golgi Structures 
For localization of Oolgi structures by indirect immunoflu- 
orescence microscopy, we used antibodies against human #- 
galactosyltransferase (7). Recent studies of tissue culture cells 
have shown the localization of this enzyme in the perinuclear 
Golgi area by immunofluorescence microscopy (7,  29) and 
the limited distribution to trans-cisternae of the Golgi com- 
plex by electron microscopy (53). 
A549 cells in interphase displayed the Golgi complex in the 
juxtanuclear area that also contains the microtubule-organ- 
izing center (Fig. 5, a and b). Incubation of A549 cells with 1 
uM  colcemid for 2-h depolymerized cytoplasmic microtu- 
bules (Fig.  5 c) and induced a  rearrangement of galactosyl- 
transferase (Fig.  5d).  The enzyme was  found dispersed in 
small vesicles  throughout the  cytoplasm. Such an effect of 
antimitotic drugs on Golgi morphology and eventually Golgi 
function(s) is well documented (29, 40, 43, 51, 62). 
Microinjection  of YL  1/2  antibody  at  a  concentration 
which affected saltatory movements, but did not aggregate 
microtubules (6 mg/ml in injection solution), did not change 
the Golgi pattern (Fig. 5, e andJ). Increasing the concentration 
of antibody in the injection solution to 12 mg/ml destabilized 
Golgi structures which appeared more vesicularized than in 
adjacent uninjected cells, but sometimes still remained in an 
asymmetric juxtanuclear position  (Figs,  5,g  and  h).  More 
often, because microtubules were aggregated,  Golgi-derived 
vesicles were randomly distributed throughout the cytoplasm 
(Fig. 5, i and j) similar to results obtained after treatment of 
cells with colcemid (Fig. 5, c and d). 
Effects of Colcemid on Cells Previously Injected 
with Antibody 
YL  1/2  antibody  was  injected  into  Swiss 3T3  cells  at 
concentrations (6 mg/ml) that induced bundling of microtu- 
bules without obvious aggregation (Fig. 6a). After incubation 
with  1 uM  colcemid  for  1  h,  the  injected  antibody  was 
diffusely distributed in the cytoplasm (Fig. 6 b); no microtu- 
bules could be detected in these cells by double immunoflu- 
orescence microscopy using polyclonal tubulin antibody (not 
shown).  Removal of colcemid allowed repolymerization of 
microtubules in the presence of injected antibody. Microtu- 
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bule bundles were formed again (Fig. 6 ¢). Repolymerization 
was  not  random but  started  from organizing centers (48), 
quite often two per cell (Fig. 6 d). Repolymerization of  micro- 
tubules starting from organizing centers in the presence of 
injected antibody could easily be detected when cells were 
allowed to recover in colcemid-free medium for a short time 
(Fig. 6, e and f). Microtubule bundles in injected cells could 
also be depolymerized by cold treatment (4"C) and repoly- 
merization occurred upon warming up injected cells to 37"C 
(not shown). 
Image Intensification Microscopy 
Rhodamine-conjugated YL  1/2 antibody (6  mg/ml) was 
injected  into  Swiss 3T3  cells  and  the  distribution  of the 
injected antibody in the living ceils was followed by image 
intensification  microscopy  (for  details  see  Materials  and 
Methods). Photographs were taken every  15  min from the 
intensifier tube and changes in the distribution of injected 
antibody could be  followed and  documented over several 
hours. Fig. 7 shows single photographs of the same 3T3 cell 
starting 2 h after injection (Fig.  7 a). The antibody induced 
bundling of microtubules. The cell showed no saltatory move- 
ments but still had disoriented ruffle activity when examined 
by time-lapse video microscopy using phase-contrast optics. 
At 30 min (Fig. 7 b) and 60 min (Fig. 7 c) later, some micro- 
tubule  bundles  have  changed  their  orientation,  but  still 
showed a good correlation to previous positions in Fig. 7 a or 
b, respectively. Most of the bundles seen in Fig.  7a can be 
traced in Fig. 7 c. As this cell was active with respect to ruffle 
activity during  1 h  of observation, alterations of cell  mor- 
phology might have indriectly changed the position of micro- 
tubule bundles. 
Microinjection of Antibodies Adsorbed to 
Colloidal Gold 
As an  approach to examine the  distribution  of injected 
antibody at the electron microscopic level,  both antibodies 
(YL  1/2 and YOL  1/34) were adsorbed to 5 nm colloidal 
gold.  Uncomplexed antibody and conjugated gold particles 
could easily be  separated by centrifugation before starting 
microinjection. After injection of gold-antibody complexes, 
the injected cells were first processed for indirect immunoflu- 
orescence (Fig.  8). 2 h after microinjection of 2 mg IgG/ml 
on  colloidal gold,  the  injected YL  1/2  antibody could be 
localized along microtubule structures (Fig. 8, a and b). When 
injected at higher concentrations (6 mg IgG/ml), typical bun- 
dles could be detected in  injected cells  (Fig.  8 c) visible  as 
phase-dense structures (Fig. 8 d), indicating the accumulation 
of  gold particles along these bundles. To examine the stability 
of antibody-gold complexes after  microinjection,  YL  1/2 
antibody on gold could be detected along microtubule struc- 
tures (Fig.  8,e-h) 24 h  after injection. In Fig.  9,  cells were 
fixed different times after injection of antibody-gold com- 
plexes and processed for electron microscopy. Colloidal gold 
particles adsorbed to YL  1/2 were found specifically  accu- 
mulated  along  microtubules  excluding  other  filamentous 
structures  (Fig.  9,A-C).  Colloidal  gold  adsorbed  to  YOL 
1/34 antibodies remained diffusely distributed after microin- 
jection into the cytoplasm (Fig. 9 D). Even 24 h after injection, 
colloidal gold adsorbed to YL  1/2 antibodies could be de- 
tected along microtubules (not shown). FIGURE 4  Distribution of intermediate filaments in Swiss 3T3 cells microinjected with YL 1[2 antibody. (a and b) indirect double 
immunofluorescence microscopy to reveal distribution of microtubules (a) and intermediate filaments  (b) in the same cell using 
YL 112 antibody and rabbit vimentin antibody followed by fluorescein-conjugated goat anti-rat  IgG and rhodamine-conjugated 
goat anti-rabbit IgG. (c)  Distribution of intermediate filaments  in a 3T3 cell treated with colcemid at 1 /~M for 8 h. (d-i)  Double 
immunofluorescence of injected 3T3 cells. Cells were microinjected with YL 1/2 antibody at 12 mglml (d, e, and f) or 6 mg/ml 
(g,  h, and i), fixed and permeabilized 8  h after injection and  labeled with rabbit vimentin antibody followed by a mixture of 
second antibodies. Cells in a, d, and g were viewed by optics selective for fluorescein to visualize microtubules (a) or injected 
antibody (d and g). The same fields were viewed with optics selective for rhodamine to visualize distribution of intermediate 
filaments (b, e, and h). Note collapse of intermediate filaments when microtubules were aggregated after injection of antibody (d 
and e). Bars, 20/~m. (a) x  400. (c) x  650. (d and g) x  500. 
DISCUSSION 
The  main  purposes  of this  study were  to  investigate  the 
following: (a) whether in vivo decoration of microtubules by 
injected antibody and possible reorganization (but not depo- 
lymerization) would interfere with microtubule functions; (b) 
whether aggregation  of microtubules induced by injection of 
high concentrations of antibody would have effects similar to 
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rescence of A549 cells.  Normal cells (a and b) or cells treated  with colcemid at 1 /~M for 2 h (c and d) were labeled with YL 1/2 
antibody and rabbit galactosyltransferase antibody followed by fluorescein-conjugated goat anti-rat IgG and rhodamine-conjugated 
goat anti-rabbit IgG. (e-j) double immunofluorescence of injected A549 cells. Cells were injected with YL 1/2 antibody at 6 mg/ 
ml  (e and f) or  12  mg/ml  (g-j),  labeled 2 h after injection with rabbit galactosyltransferase  antibody followed by a mixture of 
second antibodies. Cells in (a, c, e, g, and i) were viewed by optics selective for fluorescein to visualize distribution of microtubules 
(a and c) or of injected antibody (e, g, and i). The same fields were viewed with optics selective  for rhodamine to visualize 
distribution of galactosyltransferase  (b, d, f, h, and i).  Note specific reorganization of Golgi elements  dependent on amount of 
injected antibody and dispersion of Golgi in d and j.  Bars, 20/zm. (a and i) x  300. (c and g~.x 350. (e) x  450. 
the  treatment  of  cells  with  microtubule-depolymerizing 
agents; and (c) whether the antibody would interfere with the 
(de)polymerization of microtubules in vivo by binding to the 
tyrosylated carboxyterminus ofa-tubulin. For c, recent studies 
have suggested that the reversible posttranslational modifica- 
tion of tubulin by removal and addition of a tyrosine residue 
to the carboxyterminal glutamate of the a-chain might influ- 
ence  microtubule  assembly  in  vivo  (14,  37,  46;  see  also 
reference 6 l). 
Saltatory Movements and Cell Locomotion 
Recent studies  on  the  cytoskeletal organization  of axons 
have shown that microtubules are connected to membranous 
organelles by fine cross-bridges, indicating the involvement of 
microtubules in  active organelle transport (13,  27,  53,  54). 
The  nature  of cross-bridges  is  not  clear;  either  organelles 
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possess projections on their surface that interact with micro- 
tubule  walls,  or  MAP  form projections (see  reference  31). 
Nevertheless, these findings support the hypothesis that mi- 
crotubules serve as rails or tracks for movement of membra- 
nous organelles and  that  cross-linkers could play an  active 
role in  this process (17,  22).  Another model originally pro- 
posed by Ochs (46) suggests that vesicles and organelles could 
be bound to a transport filament like actin. These filaments 
would  move  by  interacting  with  myosin-like cross-bridges 
attached to  microtubules.  In this respect,  our results could 
indicate  that  injected  antitubulin  antibody  might  sterically 
interfere with the formation of such cross-bridges by prevent- 
ing  interaction  of either  organelle-derived projections with 
microtubule walls or of MAP-projections with the surface of 
organeUes, or by preventing the formation of cross-bridges in 
the actin-like filament transport model. On the other hand, 
the antibody, when injected into cells, might directly interfere FIGURE  6  Effects  of colcemid on  microtubule structures in Swiss  3T3  cells microinjected with YL  112 antibody. (a) A  3T3  cell 
was injected with YL 1/2 antibody (6 mg]ml), fixed 2  h  later and labeled with rhodamine-conjugated goat anti-rat IgG. (b) As in 
a, but the cell was incubated with colcemid at 1 /~M for 1 h. (c-f) As in b, but cells were allowed to recover in medium without 
drug for 1 h (c and d) or 30  min (e and f).  Note recovery of microtubules in presence of injected antibody; some cells contain 
two microtubule organizing centers. Bars, 20 urn. (a, c, and d) x  550. (b and e) x  400. (f) x  300. 
with binding of either a yet unknown MAP or other cellular 
components to the tyrosylated carboxyterminus of a-tubulin. 
It is also possible that cross-bridges  between microtubules 
and membranous organelles have some enzyme activity that 
generates the force for sliding of these organelles on microtu- 
bules (6,  11,  16, 58). Without directly preventing formation 
of cross-bridges  between  organelles  and  microtubules,  the 
antibody might affect the flexibility or conformation of these 
cross-bridges  and, thereby, inhibit "saltations" of organelles 
along microtubules. After we had submitted the present study, 
Hayden et al. (26) were able to show that in living keratocytes 
of Rana pipiens  cell  organelles and  vesicles  moved  along 
microtubules in a saltatory fashion, and the authors suggested 
a  modification of the  actin-like  filament transport  model. 
Thereafter microtubules would serve as passive tracks rather 
than being involved as a force-generating system and soluble 
myosin would be responsible for providing the force inde- 
pendent of microtubules (26).  Although we cannot exclude 
that the continuous motion of very small particles observed 
by Allen et al. (2) still takes place under conditions where we 
were able to stop saltatory movement of larger cell organelles 
and  vesicles  by injection of antibody, we would  favor the 
hypothesis that microtubules are actively involved in saltatory 
movement. This does not exclude that the actual motive force 
can be provided by another yet unidentifed system. 
Effects on the Cytoplasmic Organization of 
Microtubules 
High-voltage electron microscopic studies  of whole cells 
have revealed an extensive three-dimensional lattice of fila- 
mentous structures or microtrabeculae (14, 70, 7 l) intercon- 
necting membranous organelles, microtubules, and  plasma 
membrane. Axoplasm, when studied by quick-freeze, deep- 
etching methods, also revealed an extensive system of cross- 
links  between  microtubules,  neurofilaments, and  membra- 
nous organdies (30,  56).  In addition, it has been suggested 
that MAP could form cross-bridge-like  structures (25, 27). As 
a  result,  the tubulin  antibody, when injected into cultured 
cells,  could  prevent the  formation  of cross-links  to  other 
cellular components and thereby disrupt the highly organized 
spatial  distribution  of microtubules without  depolymeriza- 
tion.  Thus,  the  bundling of microtubules and  finally their 
collapse in antibody-injected cells can be a  secondary effect 
rather than a direct one mediated by cross-linking of micro- 
tubules by injected antibody. 
Two problems arise from the use of the YL 1/2 antibody. 
First,  the parental line of the YL  1/2 clone secretes a  light 
chain, resulting in mixtures of IgG molecules that contain the 
myeloma and antibody light chains in different combinations 
(33). Second, the concentration of antibody that is injected is 
critical. The total tubulin concentration of cultured nonneu- 
ronal cells in interphase is  ~2-3 mg/ml with some 50%  in 
the  depolymerized state  (28).  Microinjection  introduces  a 
volume of ~5-10%  of the total cellular volume (23) and 
15% of the total cellular a-tubulin purified from brain is 
tyrosylated  (61). Therefore, using 2 mg IgG/ml in the injection 
solution should be sufficient to saturate up to  20%  of the 
cellular tyrosylated tubulin with the antibody that shows  in 
vitro a dissociation constant of 5 x  10-TM (33) and therefore 
should be fully tubulin-bound. If YL 1/2 is used at concen- 
trations  of 6-12  mg  IgG/ml,  between  half and  all  of the 
cellular tyrosylated tubulin could be saturated, assuming that 
brain and cells in culture have equal percentages oftyrosylated 
tubulin. 
Although we do not know how much of the tyrosylated 
tubutin is in the polymerized state, it is interesting that the 
degree of saturation of tyrosylated tubulin  within microtu- 
bules can be correlated with the effect of saltatory movement 
and rearrangements in the distribution of cytoplasmic micro- 
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tubules. 
Alterations in the Organization of Intermediate 
Filaments and Golgi Elements 
A  characteristic property of intermediate filaments of the 
vimentin type is their aggregation into cytoplasmic or peri- 
nuclear  filament  bundles  in  cells  exposed  to  colcemid  or 
colchicine. These observations have supported the assumption 
that microtubules and certain intermediate filaments are in- 
terconnected, even though the alteration in the organization 
of intermediate filaments occurs much slower than the dis- 
ruption of microtubules caused by the drug (8, 20, 32).  The 
distribution of intermediate filaments can be specifically al- 
tered:  microinjection of some antibodies to vimentin or vi- 
mentin-associated  proteins  induces  a  rapid  and  reversible 
aggregation  of intermediate  filaments.  Under  these  condi- 
tions, the distribution  of actin filament bundles and micro- 
tubules  remains  unaltered.  Cellular  activities  such  as  cell 
locomotion and  saltatory organelle  movements were  unaf- 
fected and injected cells even divided (18, 34, 39). Interestingly 
our results show that intermediate filaments of the vimentin 
type collapse when microtubules were aggregated by injection 
of tubulin  antibody.  Thus,  the  aggregation  of intermediate 
filaments in cells treated with colcemid or colchicine is not 
necessarily attributable to a  direct effect of these drugs.  The 
nature  of a  possible  interaction  between  microtubules and 
intermediate filaments still remains unclear. 
Several observations have led to the assumption that micro- 
tubules are involved in the location and organization of Golgi 
elements.  In  interphase  cells,  the  Golgi  complex  and  the 
microtubule-organizing center are  often  found  nearby (13, 
38). The breakdown of interphase cytoplasmic microtubules 
for establishing the mitotic spindle is correlated with the loss 
of polarization and often with the fragmentation of the Golgi 
complex and is thought to guarantee an equal distribution of 
Golgi elements to the daughter cells (29; for further references, 
see reference 74).  Changes in organelle character and distri- 
bution  in  mitotic cells are  strikingly similar to  changes  in 
nonmitotic cells treated with antimitotic drugs. Colcemid and 
colchicine for example are known to induce  fragmentation 
and dislocation of Golgi elements (29, 40, 43,  51). Neverthe- 
less, disintegration of Golgi elements by colchicine was often 
considered to be produced by binding of the drug to (Golgi) 
membranes (42, 73). The redistribution of galactosyltransfer- 
ase as  a  Golgi marker upon  injection  of tubulin  antibody 
demonstrates that the organization and location of the Golgi 
complex is directly dependent  on  the  integrity  of microtu- 
bules. In agreement with these results one of us has recently 
shown that microtubule reorganization, induced by injection 
of a  nonhydrolyzable GTP analog, also affected the organi- 
zation of Golgi elements (65). 
FIGURE  7  Fluorescence intensification  microscopy of living Swiss 
3T3  cells  microinjected  with  rhodamine-conjugated  YL  1/2  anti- 
body. Photographs were taken at intervals of 30 min directly from 
the EMI intensifier tube. Fluorescent bundles seen in a can still be 
traced in c. Bars,  20 u.m. x  900. 
tubules after injection of different amounts of antibody. Per- 
haps in  interphase cells cross-linkers between microtubules, 
cell  organelles, and other cellular components are necessary 
Reorganization  of Microtubules in Interphase and 
Mitotic Cells 
In in vitro polymerization experiments, YL  1/2 antibody 
does not interfere with polymerization of microtubules (66). 
Microtubule bundles, induced by injection of antibody into 
cultured  cells,  were  readily depolymerized by treatment of 
injected cells with cold or colcemid, and repolymerized in the 
presence of antibody. On the other hand, the results obtained 
from living cells by intensification microscopy or from syn- 
chronized  cells  indicate  that  injected  cells  were  unable  to 
1486  THE  JOURNAL  OF  CELL BIOLOGY • VOLUME  97,  1983 FIGURE 8  Indirect immunofluorescence of Swiss 3T3 fibroblasts  injected with YL 1/2 antibody adsorbed to colloidal gold. Cells 
in a and b and e and fwere injected with 2 mg IgG/ml, cells in c and d and g and h with 6 mg IgG/ml. 3 h after injection (a-d) or 
24 h after injection (e-h), cells were fixed, permeabilized,  and labeled with rhodamine-conjugated  goat anti-rat  IgG. Note phase- 
dense bundles in d and h indicating accumulation of injected colloidal gold. Bars, 20/zm.  (a) x  600. (c, e, and g) x  400. 
reorganize  their  microtubules  when  these  structures  were 
highly decorated by the injected antibody. In interphase cells, 
antibody-decorated microtubule structures revealed a  static 
appearance  and  obviously did  not  disassemble  when  such 
cells  entered mitosis.  As  a  result, these  cells  never formed 
spindle microtubules. Decoration of microtubules by injected 
antibody might interfere with the ability of the cell to reor- 
ganize its microtubules in  two ways:  the injected antibody 
might block the binding of a regulatory protein to microtu- 
bules that could induce their depolymerization or, because of 
the specificity of the antibody, prevent the removal of the 
carboxyterminal tyrosine. The latter mechanism would be in 
agreement with recent findings on the reversible posttransla- 
tional modification of tubulin, whereby a tyrosine residue is 
removed and added to the carboxyterminal glutamate of the 
a-chain.  The  enzyme  that  catalyzes addition  of tyrosine, 
tubulin-tyrosine ligase, has been detected in both vertebrate 
(3, 5, 44, 49, 50) and invertebrate tissues (36). Also, another 
distinctly  different enzyme,  tubulin-tyrosine carboxypepti- 
dase,  which is believed to be responsible for the removal of 
carboxyterminal tyrosine of a-tubulin, has been detected and 
characterized (1,  37).  The existence of these  two  enzymes 
makes it possible that there is probably a  cyclic process of 
tyrosylation and detyrosylation that might be important in 
modulating the activity of tubulin in cells. So far the func- 
tional significance of tyrosylation and detyrosylation remains 
unclear and further studies are necessary to confirm such a 
mechanism with respect to possible regulation of microtubule 
polymerization in vivo. 
We are indebted to Dr. J.  V. Kilmartin for supplying us generously 
and constantly with the monoclonal tubulin antibodies, to Dr. E. G. 
Berger  for a  gift  of human galactosyltransferase antibodies, and to 
Dr.  D.  J.  P.  FitzGerald for preparation of colloidal gold-antibody 
complexes.  We  wish  to  thank  Dr.  I.  Pastan  for  his  support  and 
suggestions,  Dr. I.  V.  Sandoval and Dr.  M.  Gottesman for helpful 
discussions, Drs. P. Harris and M. Osborn for critically reading and 
helpful suggestions concerning the revised manuscript, R. Steinberg 
for photography, and R.  M.  Coggin and R.  Hasse for typing this 
manuscript. 
J.  Wehland was  supported by a  long-term fellowship  from  the 
European Molecular Biology Organization. 
Received  for publication  28 February  1983, and in revised form 12 
July 1983. 
WEHLAND AND WILLINGHAM  A Monoclonal Antibody Specific for Tyrosylated  a-Tubulin  1487 1488  THE  JOURNAL OF  CELL BIOLOGY - VOLUME 97,  1983 REFERENCES 
1.  Agarana, C. E..  H. S. Barra, and R. Caputto.  1980. Tubulin-tyrosine carboxypeptidase 
from chicken brain: properties and partial purification. J. Neurochem.  34:114-118. 
2.  Allen.  R. D., I. lasaki, S. T. Brady, and S. P. Gilbert.  1982.  Fast axonal transport  in 
squid giant axon. Science ( Wash, DC). 218:1127-1129. 
3.  Arce, C. A., H. S. Barra, J. A. Rodriguez, and R. Caputto.  1975. Tentative identification 
of the amino acid that binds tyrosine as a single unit into a soluble  brain protein. FEBS 
(Fed. Eur Biochem.  Soc.) Lett. 50:5-7. 
4.  Aree, C. A., M. E. Hallak, J. A. Rodriguez, H. S. Barra, and R. Caputto.  1978. Capability 
of tubulin and mierotubules to incorporate and to release  tyrosine and phenylalanine 
and  the  effect  of the  incorporation  of these  amino  acids  on  tubulin  assembly.  J. 
Neurochem. 31:205-210. 
5.  Barra,  H.  S.,  C.  A.  Arce,  J.  A.  Rodriguez,  and  R.  Caputto.  1974.  Some common 
properties of the protein that incorporates tyrosine as a single unit and the microtubule 
proteins.  Biochem.  Biophys.  Res. Commun. 60:1384-1390. 
6.  Beckerle,  M. C., and K. R. Porter.  1982. lnhibitors ofdynein activity block intracellular 
transport in erythrophores. Nature (Lond). 295:701-703. 
7.  Berger,  E. G.. T. Mandel, and  U. Schilt.  1981.  Immunohistochemical localization  of 
galactosyltransferase  in  human  fibroblasts  and  HeLa cells.  J.  Histoehem.  Cytochem. 
29:364-370. 
8.  Blose, S. H., and S. Chacko.  1976. Rings of intermediate (100 ,~) filament bundles in 
the perinuclear region of vascular endothelial cells. Their mobilization by colcemid and 
mitosis..L Cell Biol.  70:459-466. 
9.  Blose,  S.  H.,  D. I. Meltzer,  and J.  R.  Feramisco.  1982.  10-nm  filaments induced  to 
collapse  in cells  microinjected with antibodies against tubulin.  J  Cell BioL  95(2,  Pt. 
2):229a. (Abstr.) 
10.  Cabral,  F.,  M. C.  Willingham, and  M.  M. Gottesman.  1980.  The localization  of an 
insoluble  58 K protein from Chinese hamster ovary cells to 10 nm filaments in cultu~d 
fibroblasts by electron  microscopic immunocytochemistry. J.  Histochem.  Cytc~'hem. 
28:653-663. 
11.  Clark, T. G., and J. L. Rosenbaum.  1982. Pigment particle translocation in detergant- 
permeabilized  melanophores  of Fundus  heterocfitus.  Proc. Natl.  Acad  Sci.  USA. 
79:4655-4659. 
12.  De Mey. J., M. Moeremans, G. Geuens, R. Nuydens, and M. De Brabander.  1981. High 
resolution  light and electron microscopic localization  of tubulin with the IGS (immuno 
gold staining) method. Cell BioL Int.  Rep. 5:889-899. 
13.  Dustin, P.  1978. Microtubules. Springer-Verlag,  New York. 
14.  Ellisman, M. H., and K. R. Porter.  1980. Microtrabecular structure of the axoplasmic 
matrix:  visualization  of cross-linking structures  and  their  distribution.  J.  Cell Biol. 
87:464-479. 
15.  Faulk, W.  R.,  and G. M. Taylor.  1971.  An immunocolloid  method for the electron 
microscope, lmmunochemistry.  8:108 I- 1083. 
16.  Forman, D. S. 1982. Vanadate inhibits saltatory organelle movement in a permeabilized 
cell model. Exp. Cell Res.  141:139-147. 
17.  Freed, J. J.,and M. M. Lebowitz.  1970. The association ofaclass ofsaltatory movements 
with microtubules in culture cells. J. Cell BioL 45:334-354. 
18.  Gawlitta, W., M. Osborn, and K. Weber. 1981. Coiling of  intermediate filaments induced 
by microinjection of a  vimentin-specific antibody does not interfere with locomotion 
and mitosis. Eur.  J. Cell Biol.  26:83-90. 
19.  Geoghegan, W. D., and G. A. Ackerman.  1977. Adsorption of horseradish peroxidase, 
ovomucoid  and  anti-immunoglobulin  to  colloidal  gold  for the  indirect detection  of 
concanavalin A, wheat germ agglutinin and goat antihuman immunoglobulin G on cell 
surfaces at the electron  microscopic level:  a  new method, theory and application..i,. 
Histochem.  Cytochem.  25:1187-1200. 
20.  Goldman,  R. D.  1971. The role of three cytoplasmic fibers in BHK21 cell motility. I. 
Microtubules and the effects of colchicine.  J. Cell Biol.  51:752-762. 
21.  Goldman,  R. D., T. D. Pollard,  and J. Rosenbaum, editors.  1976. Cell  Motility.  CoM 
Spring  Harbor Conf Cell Proliferation.  Vol. 3 (Book A). 
22.  Grafstein, B., and D. S. Forman. 1980. lntracellular transport in neurons. Physiol.  Rev. 
60:1167-1283. 
23.  Graessmann,  M.,  and  A. Graesmann.  1976.  "Early" Simian-Virus-40-spacific RNA 
contains  information  for tumor antigen  formation and  chromatin  replication.  Prt~'. 
Natl.  Acad Sci.  USA.  73:366-370. 
24.  Green,  K.,  and  R.  D.  Goldman.  1982. The  effects  of taxol  on  microtubule  and 
intermediate  filament distribution  in cultured  fibroblasts  and epithelial  ceils.  J.  Cell 
Biol.  95(2,  Pt. 2):235a.  (Abstr.) 
25.  Griffith,  L.  M.,  and  T.  D.  Pollard.  1978. Evidence  for actin  filament-microtubule 
interaction by microtubule-associated proteins..L Cell BioL 78:958-965. 
26.  Hayden,  J.  H.,  R.  D.  Allen,  and  R.  D.  Goldman.  1983.  Cytoplasmic transport  in 
keratocytes: direct visualization of particle translocation along microtubules. Cell Motil 
3:1-19. 
27.  Heuser, J.  E..  and  M.  Kirschner.  1980.  Filament organization revealed in  platinum 
replicas  of freeze-dried  cytoskeletons.  J. Cell Biol.  86:212-234. 
28.  Hiller, G., and K. Weber. 1978. Radioimmunoassay for tubulin: a quantitative compar- 
ison of tubulin  content  of different established  tissue culture  cells  and  tissues.  Cell. 
14:795-804. 
29.  Hiller,  G.,  and  K.  Weber.  1982.  Golgi detection  in  mitotic and  interphase cells  by 
antibodies to secreted galactosyltransferase.  Exp. Cell Res.  142:85-94. 
30.  Hirokawa, N.  1982.  Cross-linker system between  neurofilaments,  microtubules,  and 
membraneous  organelles  in  frog axons  revealed  by  the  quick-freeze,  deep-etching 
method. J. Cell Biol.  94:129-142. 
31.  Hyams, J. S., and H. Stebbinds.  1979.  Microtubule associated  transport. In Microtu- 
bules.  K. Roberts and J. S. Hyams, editors.  Academic Press, Inc., New York. 487-530. 
32.  Hynes, R. O., and A. T. Destree.  1978. 10 nm filaments in normal and transformed 
cells. Cell.  13:151-163. 
33.  Kilmartin, J. V.,  B. Wright, and C. Milstein.  1982.  Rat monoclonal  antitubulin  anti- 
bodies derived by using a new nonsecreting rat cell line. J. Cell Biol.  93:576-582. 
34.  Klymkowsky, M. W. 1981. Intermediate filaments in 3T3 cells collapse after intracellular 
injection ofa monoclonal anti-intermediate filament antibody. Nature (Lond.).  291:249- 
251. 
35.  Klymkowsky, M.  W.  1982.  Vimentin and  keratin  intermediate  filament systems in 
cultured PtK2 epithelial  cells are interrelated.  EMBO (  Eur.  Mol. Biol.  Organ.) J. 1  : 161- 
165. 
36.  Kobayashi,  T.,  and  M.  Flavin.  1981. Tubulin  tyrosylation  in  invertebrates.  Comp. 
Biochem.  Physiol.  B Comp. Biochem.  69B:387-392. 
37.  Kumar, N., and M. Ravin. 1981. Preferential  action of a brain detyrosylating carboxy- 
peptidase on polymerized tubulin. J, Biol.  Chem, 256:7678-7686. 
38.  Kupfer, A., D. Louvard, and S. J. Singer.  1982. Polarization of the Golgi apparatus and 
the microtubule-organizing center in cultured fibroblasts  at the edge of an experimental 
wound. Pr¢x'. Nail.  Acad.  Scl.  USA.  79:2603-2607. 
39.  Lin, J. J.-C., and J. R. Feramisco.  1981.  Disruption of the in  vivo distribution of the 
intermediate filaments in fibrnblasts  through the microinjection of a specific monoclonal 
antibody. Cell. 24:185-193. 
40.  Lin, J. J.-C., and S. A. Queally.  1982.  A monoclonal  antibody that recognizes Golgi- 
associated  proteins of cultured fibroblast  cells. J. Cell Biol.  92:108-112. 
41.  Mabuchi, 1., and  M. Okuno.  1977. The effect  of myosin antibody on the division of 
starfish blastomeres. J. Cell Biol.  74:251-264. 
42.  Mitranic, M. M., J. M. Boggs, and M. A. Moscarello.  1981. An effect of colchicine on 
galactosyl-  and sialytransferase  of rat liver Golgi membranes. Biochim.  Biophys.  Acta. 
672:57-64. 
43.  Moskalewski,  S.. J. Thyberg, S. Lohmander, and U. Friberg.  1975. Influence ofcolchicine 
and vinblastine on the Golgi complex and matrix deposition in chondrocyte aggregates. 
Exp. Cell Res.  95:440-454. 
44.  Nath, J., and M. Flavin. 1979. Tubulin tyrosylation in vivo and changes accompanying 
differentiation of  cultured neuroblastoma-glioma hybrid cells. J. Biol. Chem. 254:11505- 
11510. 
45.  Nath, J., M.  Flavin, and E. Schiffman. 198l.  Stimulation of tubulin tyrosinolation in 
rabbit  leukocytes  evoked by the chemoattractant  formyl-methionyl-leucyl-phenylala- 
nine. J. Cell Biol.  91:232-239. 
46.  Ochs,  S.  1974.  Systems of material  transport  in  nerve fibers (axoplasmic transport) 
related  to nerve function and trophic control.  Ann. N  Y. Acad.  Sei.  228:202-223. 
47.  Olmsted, J. B., and G. G. Borisy.  1973. Characterization of microtubule assembly in 
porcine brain extracts by viscometry. Biochemistry.  12:4282-4-4289. 
48.  Osbom, M., and K. Weber.  1976. Cytoplasmic microtubules appear to grow from an 
organizing structure towards the plasma membrane. Proc, Nail, Acad. Sci.  USA.  73:867- 
870. 
49.  Preston, S. F., G. G. Deanin, R. K. Hanson, and M. W. Gordon.  1979. The phylogenetic 
distribution of tubulin: tyrosine ligase. J. Mol. Evolution.  13:233-244. 
50.  Raybin,  D., and  M.  Flavin.  1975.  An enzyme tyrosylating a-tubulin  and  its role  in 
microtubule assembly. Biochem.  Biophys.  Res. Commun. 65:1088-1095. 
51.  Robbins,  E.,  and  N. K. Gonatas.  1964.  Histochemical and  ultrastructural  studies on 
HeLa cell cultures exposed to spindle inhibitors with special  reference to the interpbase 
cell. J. Histochem.  Cytoehem,  12:704-711. 
52.  Roberts, K., and J. S. Hyams, editors.  1979. Microtubules.  Academic Press,  Inc.,  New 
York. 
53.  Roth, J., and E. G. Berger.  1982. lmmunocytochemical localization  of galactosyltrans- 
ferase  in  HeLa  cells:  codistribution  with  thiamine  pyrophosphatase  in  trans-Golgi 
cisternae.  J  Cell Biol.  93:223-229. 
54.  Schiff,  P. B., J. Fant, and S. B. Horwitz.  1979. Promotion of microtubule assembly in 
vitro by taxol.  Nature (Lond.).  277:665-667. 
55.  Schiff, P. B., and S. B. Horwitz. 1980. Taxol stabilizes  microtubules in mouse fibroblast 
cells. Proc. Natl. Acad,  Sci.  USA,  7:1561-1565. 
56.  Schnapp, B. J., and T. S. Reese. 1982. Cytoplasmic structure in rapid-frozen axons. J. 
Cell Biol. 94:667-679. 
57.  Smith,  D.  S.  1971. On  the  significance of cross-bridges  between  microtubules  and 
synaptic vesicles. Philos.  Trans.  R. Soc. Lond. B. Biol.  Sci.  261:395--405. 
58.  Stearns,  M.  E.,  and  R.  L.  Ochs.  1982.  A  functional  in  vitro  model  for studies  of 
intracellular  motility in digitonin-permeabilized erythrophores. J. CelIBioL  94:727-739. 
59.  Taylor. E.  W.  1965.  The mechanism of colchicine inhibition of mitosis. J. Cell BioL 
25:145-160. 
60.  Taylor, D. L.,  and Y.-L. Wang.  1980.  Fluorescentlv  labeled  molecules can probe the 
structure and function of living cells. Nature(Lond.~  284:405-410. 
61.  Thompson, W. C. 1982. The cyclic tyrosination/detyrnsination  ofalpha-tubulin.  Meth- 
ods Cell Biol.  24:235-255. 
62.  Thyberg, J., S. Nilsson, S. Moskalewski,  and A. Hinek.  1977.  Effects of colchicine on 
the Golgi complex and  lysosomal  system of chondrocytes  in  monolayer culture.  An 
electron microscopic study. Cytobiologie.  15:175-191. 
63.  Wehland, J., M. Osborn, and K. Weber. 1977. Pballoidin-induced actin polymerization 
in the cytoplasm of cultured cells interferes with cell locomotion and growth. Proe. Natl. 
Acad.  Sci.  USA.  74:5613-5617. 
64.  Wehland,  J., D. J.  P.  FitzGerald, and  M. C. Willingham.  1982.  Microinjection  of a 
monoclonal antitubulin antibody into cultured cells interferes with the organization and 
function of microtubules. J. Cell Biol.  95(2,  Pt. 2):345a.  (Abstr.) 
65.  Wehland, J., and 1. V. Sandoval.  1983. Cells  injected with guanosine 5'-[a,#-methyl- 
ene]triphosphate, an a,#-nonhydrolyzable  analog of GTP, show anomalous patterns of 
tubulin  polymerization  affecting cell  translocation,  intracellalar  movement, and  the 
organization of Golgi elements. Proc. NatL Acad.  Sci.  USA.  80:1938-1941. 
66.  Wehlaod, J., M. C. Willingham, and I. V. Sandoval. A rat monoclonal  antibody that 
FIGURE 9  Electron microscopy of Swiss 3T3 fibroblasts  injected with YL 1/2 antibody adsorbed to colloidal gold. (a, b, and c) 
cells were injected with YL 1/2 antibody adsorbed  to colloidal gold (2 mg IgG/m[), fixed 3 h after injection and processed for 
electron microscopy.  Colloidal gold  (arrowheads)  is  specifically  accumulated along microtubules (mt), but  not along other 
filamentous structures (f). (d) YOL 1/34 antibody adsorbed to colloidal remains diffusely distributed. G, Golgi. Bars, 0.1 #M. (a) 
x  52,000; (b and c) x  90,000; and (d) x  30,000. 
WEHLAND AND WILLINGHAM  A Monoclonal Antibody Specific for Tyrosylated a-Tubulin  1489 reacts specifically with the tyrosylated  form ofa-tubulin. 1. Biochemical characterization, 
effects  on  microtubule  polymerization  in  vitro and  microtubule  polymerization  and 
organization in vivo. J. Cell Biol. 97:1467-1475. 
67.  Willing,  ham, M. C., and I. Pastan.  1975. Cyclic AMP and cell morphology in cultured 
fibroblasts.  Z  Cell Biol. 67:146-159. 
68.  Willing,  ham, M.  C., and  I.  Pastan.  1978. The visualization of fluorescent  proteins in 
living cells by video intensification microscopy (VIM). Cell.  13:501-507. 
69.  Willingham. M. C., S. S. Yamada, and I. Pastan.  1980. Ultrastructural  localization  of 
tubulin in cultured fibroblasts..L  Histochem.  Cytochem.  28:453--462. 
70.  Willingham,  M. C.,  and  I. Pastan,  1983. Intensification techniques  for detection  of 
proteins in cultured cells by fluorescence  microscopy. Methods Enzymol. In press. 
71.  Wolosewick,  J. J., and K. R. Porter.  1976. Stereo high-voltage electron microscopy of 
whole cells of human diploid line WI-38. Am..L Anal.  147:303-324. 
72.  Wolosewick,  J. J., and K. R. Porter.  1979. The microtrabecular lattice of the cytoplasmic 
ground substance: artifact or reality? J. Cell. Biol, 82:114-139. 
73.  Wunderlich, F., R. Muller,  and V. Sixth. 1973. Direct evidence for a colchicine-ioduced 
impairment in the mobility of membrane components. Science(Wash.  DC).  182:1136- 
1138. 
74.  Zeligs, J. D., and S. H. Wollman.  1979. Mitosis in rat thyroid epithelial  cells in vivo. 1. 
Ultrastructural changes in cytoplasmic organdies during the mitotic cycle. J. Ultrastruct. 
Res. 66:53-77. 
75.  Zieve, G. W., D. Turnbull,  J.  M. Mullins,  and J. R.  Mclntosh.  1980. Production  of 
large numbers of mitotic mammalian cells by use of the reversible  microtubule inhibitor 
nocodazole.  Exp, Cell Res.  126:397-405. 
1490  THE  JOURNAL OF  CELL BIOLOGY • VOLUME 97,  1983 